Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates (NCT06824350)
Multi-component Chlorination Intervention to Reduce Neonatal Infections in Rural Health Facilities
🩺 Plain-English Summary (8th-Grade Level)
The CLEAN (ChLorine to reduce Enteric and Antibiotic resistant infections in Neonates) cluster randomized controlled trial in western Kenya will evaluate the impact of a multi-component chlorination intervention in health care facilities on maternal and neonatal health. Intervention facilities will receive a passive chlorination technology for water supply treatment and a reliable supply of sodium hypochlorite disinfectant. Both intervention and treatment facilities will receive infection prevention and control messaging. The goal of the study is to evaluate the impact of the intervention on bacterial contamination of water supply, on staff hands, and on high-touch surfaces in maternity wards, and the following outcomes among facility-born neonates and their mothers: (1) gut carriage of bacterial pathogens associated with sepsis one week post-birth, (2) gut carriage of antibiotic resistant bacteria one week post-birth, and (3) symptoms of possible serious bacterial infection one week following birth.
Who can join: Review the eligibility criteria below.
Location: University of California, Berkeley — Berkeley, California
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of California, Berkeley — Berkeley, California
- Kenya Medical Research Institute — Nairobi,
📞 Contact the Study Coordinator
Phone: (510) 410-2666
Email: amyjanel@gmail.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Sepsis
- A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections. — New York, New York
- Dynamics of Organ Damage and Immune Exhaustion During Sepsis — Rochester, Minnesota
- PICS: Subtitle Cardiac Dysfunction in Older Sepsis Survivors — Gainesville, Florida
- A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor — Boston, Massachusetts
- A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning — New Haven, Connecticut
- Sepsis Associated Encephalopathy (SAE) Biomarkers — Gainesville, Florida
Explore by condition: All Sepsis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.